Summary:
Accelovance has a research opportunity for men and women 40-80.
If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study.
This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD.
Health insurance is not necessary to participate.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
Have a diagnosis of moderate COPD (sometimes called emphysema or chronic bronchitis)
•
Have a history or risk of heart disease
•
Be a former or current cigarette smoker
• Participation will also depend on other requirements
Qualified Participants May Receive:
Study drug and study-related medical care at no charge and reimbursement for time and travel may be provided.